Posts in the “Targeted Therapies Targeted Therapies” category:

Therapy treats lung cancer based on patients’ genetic markers

Posted by Gianna Nannini on October 28th, 2014 |

SF Gate – October 28, 2014 – A new type of clinical trial for lung cancer patients getting under way at hospitals in the Bay Area and around the country may change the way drugs are tested in the future. That’s a pretty bold expectation, but researchers say the study — called the Lung Cancer… Read More

Advancing the development of new “targeted drug therapies” by enhancing the science of biomarkers

Posted by Samantha Powell on October 3rd, 2014 |

A key area of new drug development lies in the field of targeted therapies, sometimes called “personalized medicines,” which are drugs tailored to the genetic makeup of individual patients. These drugs are called targeted therapy because health care professionals can use clinical test results from a patient to select a specific drug that has a… Read More

MD Anderson, Foundation Medicine, team up to improve targeted therapies in metastatic disease

Posted by Samantha Powell on August 14th, 2014 |

The University of Texas MD Anderson Cancer Center announced today an alliance with Cambridge, MA-based Foundation Medicine. The teams are opening a randomized-controlled trial to determine whether targeted therapies selected based on tumor molecular profiling compared with treatment not selected on this basis results in longer progression-free survival in patients with advanced disease. This study… Read More

Possible Advance for Some Late-Stage Lung Cancer Patients

Posted by Samantha Powell on July 8th, 2014 |

Surgical biopsy is safe for certain late-stage lung cancer patients and could improve their chances of getting treated with newer types of drugs that target cancer-related genetic mutations, a new small study reveals. In many cases, surgical biopsy is too dangerous for these patients, so less-invasive methods are used, including fine-needle aspiration and core needle… Read More

Personalized Treatment Prolongs the Life of Lung Cancer Patients

Posted by Samantha Powell on March 10th, 2014 |

Date: 3/10/14 Outlet Full Name: Medical Xpress Author: No author http://medicalxpress.com/news/2014-03-personalized-treatment-prolongs-life-lung.html The National Cancer Institute (INCan) has progressed from a rate of nine months of survival to 30 with personalized treatments for patients diagnosed with lung cancer in metastatic stage, i.e., when the disease has spread to different parts of the body. In Mexico, as… Read More

Success Reported in Targeted Therapy For Common Form of Lung Cancer

Posted by Samantha Powell on February 4th, 2014 |

News Headline: Success Reported in Targeted Therapy For Common Form of Lung Cancer Date: 2/4/14 Outlet Full Name: Medical News Today Author: No author http://www.medicalnewstoday.com/releases/272058.php The most common genetic subtype of lung cancer, which has long defied treatment with targeted therapies, has had its growth halted by a combination of two already-in-use drugs in laboratory… Read More

Study Reports Success in Targeted Therapy for Common Form of Lung Cancer

Posted by Samantha Powell on January 31st, 2014 |

News Headline: Study Reports Success in Targeted Therapy for Common Form of Lung Cancer Date: 1/31/14 Outlet Full Name: Medical Xpress Author: No author http://medicalxpress.com/news/2014-01-success-therapy-common-lung-cancer.html The most common genetic subtype of lung cancer, which has long defied treatment with targeted therapies, has had its growth halted by a combination of two already-in-use drugs in laboratory… Read More

Molecular and Protein- Targeting Therapies Best for Lung Cancer With KRAS Mutation

Posted by Samantha Powell on January 20th, 2014 |

Date: 1/20/14 Outlet Full Name: Oncology Nurse Advisor Author: Kathy Boltz http://www.oncologynurseadvisor.com/molecular-and-protein-targeting-therapies-best-for-lung-cancer-with-kras-mutation/article/329960/ Therapies specifically targeting the molecular profile of non-small cell lung cancer (NSCLC) with mutated KRAS, a cancer-causing protein, are the most effective treatment strategies for patients with NSCLC. These findings were presented at the American Association for Cancer Research–International Association for the Study… Read More

Targeted Treatment Better than Chemo in Some Lung Cancers

Posted by Samantha Powell on January 13th, 2014 |

Date: 1/13/14 Outlet Full Name: Drug Discovery & Development Author: No author http://www.dddmag.com/news/2014/01/targeted-treatment-better-chemo-some-lung-cancers Patients with lung cancer who also have a specific gene rearrangement do better on a new targeted therapy compared with standard chemotherapy, according to a study by academics from the Manchester Cancer Research Centre (MCRC). Around 2 percent of patients with non-small… Read More

Targeted Treatment Better than Chemo in Some Lung Cancers

Posted by Samantha Powell on January 13th, 2014 |

News Headline: Targeted Treatment Better than Chemo in Some Lung Cancers Date: 1/13/14 Outlet Full Name: Drug Discovery & Development Author: No author http://www.dddmag.com/news/2014/01/targeted-treatment-better-chemo-some-lung-cancers Patients with lung cancer who also have a specific gene rearrangement do better on a new targeted therapy compared with standard chemotherapy, according to a study by academics from the Manchester… Read More